INTERNE UV-THERAPIE

Patent europeic · EP4196212 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4196212
Numer da la dumonda
EP21856823
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-08-2021
Publitgà
21-06-2023
Concedì
30-09-2026
La protecziun finescha il pli tard
12-08-2041
Proxima taxa annuala scadenta
31-08-2027
Classas IPC
A61N 5/06 (2006.01)
A61M 39/16 (2006.01)
A61B 1/06 (2006.01)
A61B 18/18 (2006.01)
A61B 18/24 (2006.01)
A61L 2/10 (2026.01)
A61B 18/00 (2006.01)
Prioritad
US 202063065167 P 13.08.2020
Dumonda PCT
PCT/US2021/046011 13.08.2021
Publicaziun PCT
WO2022/036263 17.02.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-09-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 30.09.2026

Partidas

Possessur

Cedars-Sinai Medical Center

8700 Beverly Boulevard, Los Angeles, CA 90048, US

Inventur

REZAIE, Ali

Beverly Hills, California 90210, US

PIMENTEL, Mark

Los Angeles, California 90034, US

MELMED, Gil Y.

Los Angeles, California 90035, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.